93 7350 93 7350 (Lansoprazole Delayed Release 15 mg)

Pill with imprint 93 7350 93 7350 is Blue & Pink, Capsule-shape and has been identified as Lansoprazole Delayed Release 15 mg. It is supplied by Teva Pharmaceuticals USA.

Lansoprazole is used in the treatment of barrett's esophagus; duodenal ulcer; duodenal ulcer prophylaxis; gerd; erosive esophagitis and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 7350 93 7350

Lansoprazole Delayed Release

Imprint

93 7350 93 7350

Strength

15 mg

Color

Blue & Pink

Size

16.00 mm

Shape

Capsule-shape

Availability

Rx and/or OTC

Drug Class

Proton pump inhibitors

Pregnancy Category

B - No proven risk in humans

CSA Schedule

Not a controlled drug

Labeler / Supplier

Teva Pharmaceuticals USA

Inactive Ingredients

ferrosoferric oxide, hypromellose 2910 (6 mPa.s), magnesium carbonate, methacrylic acid - ethyl acrylate copolymer (1:1) type a, propylene glycol, ferric oxide red, shellac, sucrose, corn starch, magnesium silicate, titanium dioxide, triethyl citrate, FD&C Blue No. 1

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code	Labeler / Repackager
00093-7350	Teva Pharmaceuticals USA, Inc.
42291-0364	AvKare, Inc.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer